Xinyao Pan , Xiaodan Wang , Yun Yang , Ziwei Le , Shiyu Wang , Yao Shen , Hongbo Dong , Kaifeng Lai , Congcong Lin , Chunjuan Yang , Huanjun Xu , Chunli Gan
{"title":"Synthesis of 1,8-cineole derivatives and evaluation of their cytoprotective effects against cisplatin-induced HK-2 cell injury","authors":"Xinyao Pan , Xiaodan Wang , Yun Yang , Ziwei Le , Shiyu Wang , Yao Shen , Hongbo Dong , Kaifeng Lai , Congcong Lin , Chunjuan Yang , Huanjun Xu , Chunli Gan","doi":"10.1016/j.bmc.2025.118347","DOIUrl":null,"url":null,"abstract":"<div><div>This study aimed to discover novel lead compounds for acute kidney injury (AKI) treatment by rationally designing and synthesizing 18 derivatives through structural modifications of 1,8-cineole (c0), a nephroprotective natural product. Initial in vitro screening identified derivative 3c-2 as the most promising candidate. Subsequent evaluations in cisplatin-injured HK-2 cells demonstrated that 3c-2 effectively attenuated cisplatin-induced oxidative stress by reducing reactive oxygen species (ROS) and malondialdehyde (MDA) generation, and enhancing superoxide dismutase (SOD) activity. Comprehensive evaluations combining mitochondrial membrane potential (MMP) measurements and flow cytometry-based apoptosis assays consistently demonstrated that compound 3c-2 possessed a significant inhibitory effect on apoptosis and was effective in attenuating cisplatin-induced cytotoxicity in HK-2 renal tubular epithelial cells. Molecular docking and dynamics simulations indicated stable binding between 3c-2 and PI3K, a key regulator of oxidative stress and apoptosis pathways, suggesting PI3K as the potential therapeutic target of 3c-2.</div></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":"130 ","pages":"Article 118347"},"PeriodicalIF":3.0000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089625002883","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to discover novel lead compounds for acute kidney injury (AKI) treatment by rationally designing and synthesizing 18 derivatives through structural modifications of 1,8-cineole (c0), a nephroprotective natural product. Initial in vitro screening identified derivative 3c-2 as the most promising candidate. Subsequent evaluations in cisplatin-injured HK-2 cells demonstrated that 3c-2 effectively attenuated cisplatin-induced oxidative stress by reducing reactive oxygen species (ROS) and malondialdehyde (MDA) generation, and enhancing superoxide dismutase (SOD) activity. Comprehensive evaluations combining mitochondrial membrane potential (MMP) measurements and flow cytometry-based apoptosis assays consistently demonstrated that compound 3c-2 possessed a significant inhibitory effect on apoptosis and was effective in attenuating cisplatin-induced cytotoxicity in HK-2 renal tubular epithelial cells. Molecular docking and dynamics simulations indicated stable binding between 3c-2 and PI3K, a key regulator of oxidative stress and apoptosis pathways, suggesting PI3K as the potential therapeutic target of 3c-2.
期刊介绍:
Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.
The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.